The fifth batch of nationally sourced chemical injections meets challenges

Contributor: Dr.

On June 23, the fifth batch of national procurement (hereinafter referred to as "the national procurement") will be officially launched

The biggest difference between this national procurement and the previous four batches is the injections.

1.

Second, the large decline in national procurement in the early stage

In the first four batches of national sourcing, a total of 61 injection varieties won the bid

Although the average price cut of the first four batches of national sources was only 53%, the drop in injections was much greater.

The fourth batch of nationally produced injections has an even greater decline.

3.

However, the attitude of foreign companies towards national sourcing directly affects the industry structure.

The fourth batch has 8 injections, including 6 original researches.

The fifth batch of 29 injections produced by China involves 24 original foreign-invested products.

Omega-3 fish oil medium/long-chain fat emulsion injections and fluconazole sodium chloride injections have the highest market share in the original research, which are monopolized by German Braun and Pfizer respectively.

Although since 4+7, foreign companies have taken measures such as stripping off original research drugs in response to centralized procurement, after all, the market for chemical injections is huge.

4.

As far as the national procurement of chemical drug injections is concerned, from the first three batches of water testing to the official launch of the fourth batch, this national procurement will go straight to the hinterland of chemical drug injections
.

As the coverage of bulk purchases continues to expand and the number of over-reviewed chemical drug injections continues to increase, national procurement of chemical drug injections will also enter normalization, and large-amount injections are mostly distributed in large local pharmaceutical companies and foreign companies.
Yangtze River, Hengrui, Pfizer, etc.
, which have a greater impact on the consistency evaluation of drug injections, have affected the market size of more than tens of billions, and the reshuffle of chemical drug injections is inevitable for mass purchase
.

The fifth batch of mass procurement will be carried out on June 23.
The competition of injections will be the focus.
The quotation strategy of foreign companies has attracted much attention.
The huge chemical injection market will be reshuffled.
Mass procurement will further affect the pharmaceutical industry.
Increase
.

Note: The original text has been deleted